Ticker Sentiment Dossier
HNGE sentiment intelligence
Hinge Health, Inc.
Institutional news evidence mapped by company relevance, catalyst, publisher independence, narrative direction and market response.
Executive Evidence Brief
News confirmed by price
Constructive news tone is drawn from 29 fresh independent stories, including 29 company-specific items across 13 publishers.
Latest measured observation Hinge Health (HNGE) Earnings And New Care Push Put Valuation Back In Focus simplywall.st · 08 Aug 2026 16:41What supports the read
29 current stories are mapped specifically to HNGE.
The read spans 13 publishers rather than depending on one outlet.
Cross-story agreement is 88/100, indicating a comparatively coherent tape.
Constructive news tone is being confirmed by positive weekly price action.
What tempers the read
No material evidence constraint is currently dominant.
Narrative Trajectory
Tone and story flow over 21 days
Confidence Architecture
What makes the signal dependable
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Market Confirmation
Sentiment against the 26-week price path
Constructive news tone is being confirmed by positive weekly price action.
Catalyst Map
What is moving the narrative
Publisher Structure
Who controls the read
Topic Surface
Recurring narrative themes
Signal Memory
Score over time and signal memory
Auditable Evidence Ledger
The headlines behind the classification
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
Hinge Health (HNGE) Earnings And New Care Push Put Valuation Back In Focus
- Published
- 08 Aug 2026 16:41
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (NYSE:HNGE) Cut to Hold at Wall Street Zen
- Published
- 08 Aug 2026 07:09
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2026 results on Aug. 10, after the closing bell. In the last reported quarter, the company's loss per share of 18 cents lagged the Zacks Consensus Estimate of earnings per share of 4 cents. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on one occasion and missed thrice, delivering a negative earnings surprise of 84.7%, on average. Let's check out the factors that have shaped HIMS' performance prior to this announcement. Factors to Note Before Hims & Hers Reports Hims & Hers' second-qua
- Published
- 07 Aug 2026 17:54
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Stock Defies Rich P E On Strong Margins
Hinge Health (HNGE) shares rose 1.7% after strong Q2 2026 results, reporting US$213m revenue, US$62m operating income, and US$100m free cash flow, indicating robust profitability and operating leverage. The company's multi-condition platform strategy, including the migraine progr
- Published
- 07 Aug 2026 03:41
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (NYSE: HNGE) posts 212,817 Q2 revenue and net income
- Published
- 07 Aug 2026 01:04
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Agrees To Acquire A Digestive Care Company And Enters GI Care
- Published
- 06 Aug 2026 17:13
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Raised Guidance And Bought Back Shares, Is The Stock Still Cheap?
- Published
- 06 Aug 2026 09:12
- Catalyst
- Guidance
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health expands into gastrointestinal care with $105M acquisition
- Published
- 06 Aug 2026 09:02
- Catalyst
- Deals and strategy
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health, Inc. Stock 12‑Month Price Target Raised to $101.67, Implies 28% Upside
- Published
- 05 Aug 2026 17:20
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up
- Published
- 05 Aug 2026 16:40
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health shares climb as investors appear to cheer post-earnings momentum
- Published
- 05 Aug 2026 16:26
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Wells Fargo & Company Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock
- Published
- 05 Aug 2026 15:50
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Citizens Jmp Issues Positive Forecast for Hinge Health (NYSE:HNGE) Stock Price
- Published
- 05 Aug 2026 15:43
- Catalyst
- Guidance
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (NYSE:HNGE) Shares Up 9.5% After Strong Earnings
- Published
- 05 Aug 2026 15:17
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Is Up 5.5% After Raising 2026 Outlook And Announcing Cylinder Deal
- Published
- 05 Aug 2026 15:15
- Catalyst
- Guidance
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
RBC Capital Adjusts Hinge Health Price Target to $110 From $75, Maintains Outperform Rating
- Published
- 05 Aug 2026 12:36
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health, Inc. Q2 2026 Earnings Call Summary
- Published
- 05 Aug 2026 12:30
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Morgan Stanley Adjusts Price Target on Hinge Health to $117 From $108, Maintains Overweight Rating
- Published
- 05 Aug 2026 09:34
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health Q2 Earnings Call Highlights
- Published
- 05 Aug 2026 07:04
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) CFO relinquishes shares to cover RSU tax withholding
Hinge Health's CFO, James Budge, reported an exempt transaction where he relinquished 4,614 shares of Class A Common Stock. These shares, valued at $74.71 each, were cancelled to cover federal and state tax withholding obligations stemming from the vesting of restricted stock uni
- Published
- 05 Aug 2026 00:11
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health Inc. (HNGE) Q2 Earnings Meet Estimates
- Published
- 04 Aug 2026 23:00
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health plans GI care in one app; 69% of counties lack gastroenterologists
- Published
- 04 Aug 2026 20:05
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Earnings Date and Reports 2026
- Published
- 04 Aug 2026 07:00
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
This article reports on analyst ratings for three healthcare companies: Neogen (NEOG), Pfizer (PFE), and Hinge Health, Inc. Class A (HNGE). Neogen received a Hold rating from William Blair, while Pfizer also received a Hold rating from RBC Capital and Citi. Hinge Health, Inc. Cla
- Published
- 01 Aug 2026 13:11
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Stock Looks Fairly Valued As Its 66% Run Continues
Hinge Health (HNGE) has seen a 65.8% stock gain over the past year, leading to its current valuation being closer to fairly priced than clearly cheap. The company's P/S ratio of 9.0x is higher than the industry average, but its fair P/S multiple is estimated at 8.3x, suggesting i
- Published
- 28 Jul 2026 12:46
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Tesla Stock And 2 Fast Growth Picks Backed By High Insider Ownership
This article identifies three fast-growing stocks—Tesla (TSLA), Orla Mining (OLA), and Hinge Health (HNGE)—that also have high insider ownership, aligning management and investor interests. Each company is analyzed for its growth prospects, market position, and potential risks, e
- Published
- 25 Jul 2026 23:40
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
AppLovin Stock Leads 3 High Growth Insider Owned Tech Picks
This article highlights three fast-growing tech stocks with high insider ownership: Klarna Group (KLAR), Hinge Health (HNGE), and AppLovin (APP). The report details each company's operations, market cap, and key considerations for investors, emphasizing how insider ownership alig
- Published
- 25 Jul 2026 10:41
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Super Micro Computer Stock And 2 Fast Growing Insider Owned Picks
This article highlights three fast-growing stocks with high insider ownership: Ivanhoe Mines (TSX:IVN), Hinge Health (NYSE:HNGE), and Super Micro Computer (NasdaqGS:SMCI). It provides an overview of each company's operations, market cap, and investment appeal, focusing on their g
- Published
- 23 Jul 2026 10:11
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Hinge Health (HNGE) Stock Draws Focus After Insight Holdings Cuts Its Stake
Insight Holdings Group has significantly trimmed its stake in Hinge Health (HNGE) despite the company's recent revenue growth and improved guidance, alongside reported efficiency gains from AI automation. Hinge Health's stock has shown strong performance, with returns of 37.7% ov
- Published
- 15 Jul 2026 18:40
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Form 4 Hinge Health Inc For: 9 July By Investing.com
- Published
- 10 Jul 2026 01:34
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Interpretation Discipline
How to read this dossier
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.